Skip to main content
. 2011 Apr 17;12(4):459–466. doi: 10.1007/s10194-011-0340-6

Table 1.

Demographics and migraine information for patients and controls

Chronic migraine with drug overuse Episodic migraine Controls
N (females) 42 (39) 42 (35) 41 (30)
Age, mean (SD), years 41.21 (8.20) 36.19 (8.66) 37.12 (8.59)
Years of education <12 years (17) <12 years (16) <12 years (9)
12–16 years (16) 12–16 years (14) 12–16 years (17)
>16 years (9) >16 years (12) >16 years (15)
Years with migraine <5 years (5) <5 years (9)
5–15 years (13) 5–15 years (15)
>15 years (24) >15 years (18)
Medication overuse NSAIDs (21), triptans (3), simple analgesics (4), combination of the above (14)
Preventive medication Combinationa (15), amitriptyline (4), topiramate (4), zonisamide (1), beta-blockers (3), lamotrigine (1), flunaricine (1), SSRI (2), no treatment (11) No treatment (26), beta-blockers (7), amitriptyline (7), flunaricine (2)
Follow-up at 1 year Overuse persisted (24) Continued without overuse (35)
Ceased overuse (16) Started overuse (3)
Lost to follow-up (2) Lost to follow-up (4)

NSAIDs Non-steroidal anti-inflammatory drugs, SSRI selective serotonin reuptake inhibitors

aMore than one drug (valproic acid, zonisamide, topiramate, beta-blockers)